SCHEMBL4958043

SCHEMBL4958043

Nc1ccccc1C(=O)Nc1ccc(CNC(=O)O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.63
KDM4E B2RXH2 4/20 0.63
ALDH1A1 P00352 3/20 0.63
PTGS1 P23219 1/20 0.56
NSD2 O96028 2/20 0.52
HSD17B10 Q99714 2/20 0.52
FADS1 O60427 2/20 0.51
FFAR1 O14842 1/20 0.51
ABCB1 P08183 1/20 0.50
ABCG2 Q9UNQ0 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
CYP2C19 P33261 1/20 0.50
NR1H4 Q96RI1 1/20 0.49
APEX1 P27695 1/20 0.49
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
P2RX1 P51575 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4954215 0.83 PTGS1 (0.67) HPGDKDM4EALDH1A1PTGS1HSD17B10
SCHEMBL17744848 0.83 PTGS1 (0.75) HPGDKDM4EALDH1A1PTGS1HSD17B10
SCHEMBL5853912 0.82 FFAR1 (0.69) ALDH1A1PTGS1HSD17B10FADS1FFAR1
SCHEMBL27483855 0.82 KLKB1 (0.64) PTGS1FADS1ABCB1ABCG2NPC1
SCHEMBL2127535 0.81 PTGS1 (0.69) HPGDKDM4EALDH1A1PTGS1HSD17B10
SCHEMBL30830441 0.81 PTGS1 (0.69) HPGDKDM4EALDH1A1PTGS1HSD17B10
SCHEMBL1140055 0.81 PTGS1 (0.68) HPGDKDM4EALDH1A1PTGS1HSD17B10
SCHEMBL27541341 0.80 PTGS1 (0.56) KDM4EALDH1A1PTGS1FADS1FFAR1
SCHEMBL2236766 0.80 HPGD (0.77) HPGDKDM4EALDH1A1NSD2HSD17B10
SCHEMBL4955884 0.79 GAA (0.67) HPGDALDH1A1ABCB1ABCG2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed